In BLCA, the downregulation of PRMT5, another BLCA oncogene, resulted in a significant reduction in the expression of c-Myc, leading to the suppression of cell proliferation and invasion in 5637 and T24 cells, which was mediated through the NF-κB signal pathway. The gene discussed is MYC; the disease is bladder transitional cell carcinoma.